Las Vegas, NV -- (SBWIRE) -- 01/17/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Alcatel Lucent SA (ADR)(NYSE:ALU), Frontier Communications Corp(NASDAQ:FTR), Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA), Amarin Corporation plc (ADR)(NASDAQ:AMRN)
Alcatel Lucent SA (ADR)(NYSE:ALU) was a volume gainer of 13.10 million shares and the average volume of the stock remained 10.46 million shares. The stock opened the session at $4.28 and finished at the end of the day at $4.20 and the stock plunged -3.89%.The market capitalization of the stock remained 10.08 billion. Alcatel Lucent Société Anonyme provides Internet protocol (IP) and cloud networking, and ultra-broadband fixed and wireless access to service providers and their customers, enterprises, and institutions worldwide.
Has ALU Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Frontier Communications Corp(NASDAQ:FTR) exchanged 11.25 million shares and the average volume remained 9.84 million shares. The stock closed the session at $4.88 with the gain of 2.42%. Frontier Communications Corporation, a communications company, provides regulated and unregulated voice, data, and video services to business, residential, and wholesale customers in the United States. Frontier Communications Corporation was founded in 1927 and is based in Stamford, Connecticut.
Will FTR Continue To Move Higher? Find Out Here
Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) enhanced 1.81% and its closing price was $6.74. The volume of the stock was 11.16 million shares and the average volume remained 29.29 million shares. The market capitalization of the stock remained 1.25 billion. The beta of the stock remained 0.83. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is headquartered in Cambridge, Massachusetts.
Why Should Investors Buy ARIA After The Recent Gain? Just Go Here and Find Out
Amarin Corporation plc (ADR)(NASDAQ:AMRN) exchanged 10.55 million shares in the previous trading session, and its average trading remained 7.05 million shares. AMRN dropped -5.83% and it closed the trading at $2.26. The market capitalization of the stock remained 390.18 million. Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.
Has AMRN Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)